Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar Continuous Pumping vs Injection with Gemcitabine-Cisplatin in NSCLC
NCT01669707Phase 2Unknown
- Sponsor
- Beijing Chest Hospital
- Start
- Apr 2011
- Primary completion
- Sep 2020
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in non-small cell lung cancer (NSCLC), sponsored by Beijing Chest Hospital. Status: unknown.
02
Drugs
endostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01669707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01669707.